Journals / Journal of Neurological Sciences (Turkish) / 2014 / Cilt: 31 - Sayı: 3

Postmenopozal Dönemdeki Kadınlarda Restless Legs Sendromunun Prevalansı ve İlişkili Özellikler

Prevalence and Features Associated With Restless Leg Syndrome in Postmenopausal Females

Pages
578–585
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Estrogen modulates dopaminergic activity in the nigrostriatal system.Menopause is characterized by hypoestrogenemia, and may be a risk factor for thedevelopment or worsening of RLS symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Animal and human studies have shown that estrogen modulates dopaminergicactivity.
📊
Key Findings & Data:The hypoestrogenic state associated with menopause, characterized by a decreasedovarian follicular response to gonadotropins and estrogen, affects the nervous system atmultiple anatomical or functional sites.Aims: We investigated the prevalence of restless leg syndrome (RLS) in postmenopausalfemales and assessed the relationship between RLS and the clinical features of menopause.Methods: We enrolled 523 menopausal females in the study.
💡
Conclusion & Impact:Estrogen modulates dopaminergic activity in the nigrostriatal system.Menopause is characterized by hypoestrogenemia, and may be a risk factor for thedevelopment or worsening of RLS symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Animal and human studies have shown that estrogen modulates dopaminergicactivity. The hypoestrogenic state associated with menopause, characterized by a decreasedovarian follicular response to gonadotropins and estrogen, affects the nervous system atmultiple anatomical or functional sites.Aims: We investigated the prevalence of restless leg syndrome (RLS) in postmenopausalfemales and assessed the relationship between RLS and the clinical features of menopause.Methods: We enrolled 523 menopausal females in the study. Of those, 334 (63.86%) did notmeet the inclusion criteria and were excluded. Of the remaining 189 postmenopausal patients,73 met all of the diagnostic criteria for RLS; however, 47 of those had at least one factorrelated to secondary RLS and were excluded from the study. The remaining 26 (18.3%)postmenopausal patients with idiopathic RLS were categorized as group 1. The control groupincluded 56 postmenopausal females free of RLS and matched by age (+2 years) to group 1.Results: Onset age of menopause was earlier and surgical menopause was more frequent ingroup 1. The Pearson's correlation test revealed a strong and significant correlation betweenthe onset ages of menopause and RLS.Conclusions: Estrogen receptors are widely distributed throughout the central and peripheralnervous systems. Estrogen modulates dopaminergic activity in the nigrostriatal system.Menopause is characterized by hypoestrogenemia, and may be a risk factor for thedevelopment or worsening of RLS symptoms.

Özet

Amaç: İnsan ve hayvan çalışmaları östrojenin dopaminerjik aktiviteyi değiştirebileceğinigöstermiştir. Ovaryan follekülerin gonadotropinler ve östrojene verdiği yanıtın azalmasıylakarakterize menopoz döneminde, hipoöstrojenemik durumun sinir sistemini pek çok anatomikve fonksiyonel bölgede etkileyebileceği kabul edilir. Çalışmamızın amacı postmenopozaldönemdeki kadınlarda Restless Legs Sendromunun (RLS) sıklığını değerlendirmektir. Ayrıcamenopozun klinik özellikleriyle RLS arasındaki ilişkiyi de araştırdık.Yöntem: Bu çalışmaya menopoz döneminde olan 523 kadın dahil edildi. 334 (63.86%) kadınbu çalışmada kullanılan kriterleri karşılamadığı için çalışmadan çıkarıldı. Sonuç olarak 189postmenopozal dönemdeki kadın değerlendirildi. Bunlar içinde 73'ü RLS'nun tüm kriterlerinikarşılıyordu. Bunların 26'sında RLS'nin sekonder nedenlerinden en az biri vardı. Bu nedenlebu hastalarda elendi. 142 hastanın 26'sı (18.3%) RLS'ye neden olan herhangi bir faktörtaşımıyordu. Bu hastalar grup 1 olarak sınıflandı. Kontrol grubu, bu grubla benzer yaşta (+2),RLS semptomları olmayan 56 postmenopozal kadından oluştu.Bulgular: Grup 1 hastalarında menopoz başlama yaşı daha erken ve cerrahi menopoz çokdaha yüksek orandaydı. Menopoz başlama yaşlarıyla RLS arasında güçlü ve anlamlıkorelasyon vardı.Tartışma: Sinir sisteminin hem santral hemde periferik kısmı yaygın olarak östrojenreseptörü içermektedir. Östrojen, nigrostriatal sistemde dopaminerjik aktiviteyideğiştirebilmektedir. Hipoöstrojenemi ile karakterize menopoz dönemi, RLS semptomlarınıbaşlatan yada kötüleştiren bir risk faktörü olarak olabilir.

🔖

Cite This Article

KAPLAN, Y., UNALDI, H. K., DEMİRTÜRK, F., KURT, S. (2022). Postmenopozal Dönemdeki Kadınlarda Restless Legs Sendromunun Prevalansı ve İlişkili Özellikler. Journal of Neurological Sciences (Turkish), Cilt: 31 - Sayı: 3, 578–585. https://ajindex.com/articles/565040

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and p athop hysiologic f eatures. J Clin Neurop hysiol 2001;18:128– 147
  2. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montp laisi J, Restless Legs Syndrome Diagnosis and Ep idemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: Diagnostic criteria, sp ecial considerations, and ep idemiology. A rep ort f rom the restless legs syndrome diagnosis and ep idemiology workshop at the National Institute of Health. Sleep Med 2003;4:101–119
  3. Cui S, Goldstein RS. Exp ression of estrogen recep tors in the dorsal root ganglia of the chick embryo. Brain Res 2000;882:236–240
  4. Disshon KA, Boj a J W, Dluzen DE. Inhibition of striatal dop amine transp orter activity by 17beta-estradiol. Eur J Pharmacol 1998;345:207–211
  5. Ellrich J, Treede RD. Convergence of nocicep tive and non-nocicep tive inp uts onto sp inal ref lex p athways to the tibialis anterior muscle in humans. Acta Physiol Scand 1998;163:391–401
  6. Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical up date. Chest 2006;130:1596–1604
  7. Garcia-Borreguero D, Larrosa O, de la Llave Y. Circadian asp ects in the p athop hysiology of the restless legs syndrome. Sleep Med 2002; 3; S17–21
  8. Ghorayeb I, Bioulac B, Scribans C, Tison F. Perceived severity of restless legs syndrome across the f emale lif e cycle. Sleep Med 2008;9:799–802
  9. Horstink M W, Strij ks E, Dluzen DE. Estrogen and Parkinson's disease. Adv Neurol 2003; 91: 107–114
  10. Hurd WW, Amesse LS, Randolp h JF. Menop ause. In: Novak's Gynecology. Berek Jonathan S. editor. 13th Ed. Turkish Translation, Istanbul, Nobel Book Comp any, 2004, pp. 1109–1139
  11. Kap lan Y, Inonu H, Yilmaz A, Ocal S. Restless legs syndrome in p atients with chronic obstructive p ulmonary disease. Can J Neurol Sci 2008;35:352–357
  12. Liu J, Chen D, Goldstein RS, Cui S. Eff ect of male and f emale sex steroids on the develop ment of normal and the transient Froriep 's dorsal root ganglia of the chick embryo. Brain Res Dev Brain Res 2005;155:14–25
  13. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Mollica G, Granieri E. Pregnancy as a risk f actor f or restless legs syndrome. Sleep Med 2004;5:305–308
  14. Manconi M, Ulf berg J, Berger K, Ghorayeb I, Wesström J, Fulda S, Allen RP, Pollmächer T. When gender matters: restless legs syndrome. Rep ort of the "RLS and woman " workshop endorsed by th